Table 2: Patients' characteristics in the orthopedic cohort and the UPOG cohort.
Caractéristiques |
Orthopedic cohort (n = 255) |
UPOG cohort (n = 214) |
p value |
|
|||
Age (years) |
87.27 (5.92) |
86.45 (6.00) |
0.14 |
Female |
192 (75.29) |
166 (77.57) |
0.56 |
Body mass index, kg/m2 |
22.49 (4.18) |
21.75 (3.73) |
0.06 |
FRACTURE |
Cervical: 128 (50.2) Pertrochanteric: 127 (49.8) |
Cervical: 112 (52.34) Pertrochanteric: 102 (47.66) |
0.64
|
Walking immediately allowed |
201 (79.45) |
188 (87.85) |
0.02 |
MEDICAL BACKGROUND |
|||
Congestive heart failure |
25 (9.84) |
18 (8.41) |
0.59 |
High blood pressure |
152 (59.84) |
126 (58.88) |
0.83 |
Diabetes |
24 (9.45) |
20 (9.35) |
0.97 |
Stroke |
38 (14.96) |
20 (9.35) |
0.06 |
Stroke with sequela hemiplegia |
6 (2.37) |
2 (0.93) |
0.30 |
Myocardial infarction |
38 (14.96) |
23 (10.75) |
0.18 |
Obliterating arterial disease of the lower limbs |
11 (4.33) |
18 (8.41) |
0.07 |
Chronic liver disease |
2 (0.79) |
1 (0.47) |
0.59 |
Peptic ulcer |
7 (2.76) |
12 (5.61) |
0.12 |
Cancer |
66 (25.98) |
62 (28.97) |
0.47 |
Cancer with metastasis |
6 (2.39) |
6 (2.8) |
0.78 |
Repeated falls |
78 (35.78) |
27 (12.68) |
< 0.001 |
Cognitive impairments |
136 (61.26) |
111 (57.22) |
0.40 |
Dementia |
93 (46.5) |
78 (36.45) |
0.04 |
Folstein’s MMSE score, /30 |
18.45 (7.46) |
20.54 (7.17) |
0.02 |
Chronic alcohol use |
11 (4.33) |
12 (5.61) |
0.52 |
Chronic lung disease |
17 (6.67) |
16 (7.51) |
0.72 |
Charlson index, /40 |
7.24 (2.47) |
7.12 (2.20) |
0.59 |
EVENTS DURING HOSPITALIZATION |
|||
Blood transfusion |
55 (24.89) |
66 (30.84) |
0.16 |
Infection |
37 (15.95) |
27 (12.62) |
0.31 |
BIOLOGICAL CHARACTERISTICS |
|||
Creatinine, µmol/L |
85.41 (39.19) |
79.89 (47.78) |
0.17 |
Creatinine clearance, ml/min (CG) |
44.96 (18.85) |
47.21 (18.66) |
0.21 |
Hemoglobin on admission, g/dL |
12.33 (1.66) |
12.06 (1.79) |
0.09 |
Platelets on admission, /mm3 |
240,160 (104,280) |
232,600 (84,620) |
0.36 |
Serum or plasma albumin, g/L |
30.80 (3.87) |
31.39 (3.80) |
0.12 |
Vitamin D, nmol/L |
52.68 (29.29) |
59.81 (34.4) |
0.03 |
TREATMENTS |
|||
Number of treatments on admission |
4.40 (3.02) |
5.29 (3.41) |
0.003 |
Antihypertensive |
152 (59.84) |
128 (60.38) |
0.95 |
Anti diabetic |
17 (6.72) |
18 (8.49) |
0.47 |
Benzodiazepine |
77 (30.56) |
59 (27.83) |
0.52 |
Antidepressant |
67 (26.48) |
64 (30.19) |
0.38 |
Neuroleptic |
11 (4.37) |
9 (4.25) |
0.95 |
Morphine |
156 (61.18) |
111 (52.11) |
0.04 |
Anti platelet agent |
95 (37.55) |
64 (30.19) |
0.09 |
Anticoagulant |
39 (15.42) |
36 (16.98) |
0.65 |
FUNCTIONAL INDEPENDENCE |
|||
ADL on admission, /6 |
4.51 (1.79) |
4.66 (1.73) |
0.36 |
ADL 6/6 on admission |
102 (45.54) |
106 (53) |
0.12 |
Parker on admission, /9 |
6.31 (2.74) |
6.34 (2.79) |
0.92 |
Parker 9/9 on admission |
92 (42.01) |
88 (44.09) |
0.55 |
DISCHARGE FROM HOSPITAL |
Rehabilitation: 183 (71.76) Home: 33 (12.94) Institution: 25 (9.8) |
Rehabilitation: 138 (64.49) Home: 48 (22.43) Institution: 24 (11.21) |
0.02
|
Data are mean +/- SD, median [25-75] interquartile, or number (percentage)